Topics

Crizotinib in #NSCLC With a MET Exon 14 Alteration: Addressing an unmet need for targeted therapy in #lungcancers http://ow.ly/mW2Z50xYj3k  #lcsmpic.twitter.com/C0PlTL1HpB

13:55 EST 17 Jan 2020 | Nature Publishing

Crizotinib in With a MET Exon 14 Alteration: Addressing an unmet need for targeted therapy in http://ow.ly/mW2Z50xYj3k 

Original Article: Crizotinib in #NSCLC With a MET Exon 14 Alteration: Addressing an unmet need for targeted therapy in #lungcancers http://ow.ly/mW2Z50xYj3k  #lcsmpic.twitter.com/C0PlTL1HpB

NEXT ARTICLE

More From BioPortfolio on "Crizotinib in #NSCLC With a MET Exon 14 Alteration: Addressing an unmet need for targeted therapy in #lungcancers http://ow.ly/mW2Z50xYj3k  #lcsmpic.twitter.com/C0PlTL1HpB"

Quick Search